The Global Ophthalmoplegia Market is driven by rising prevalence of neurological disorders
The global ophthalmoplegia market is primarily driven by the rising prevalence of neurological disorders such as Parkinson's disease, stroke, myasthenia gravis, and others. Ophthalmoplegia refers to paralysis or weakness of one or more of the extraocular muscles which leads to limitations in eye movement. It is characterized by double vision or diplopia in involved eyes. Ophthalmoplegia can occur due to neurological disorders damaging cranial nerves that innervate the extraocular muscles or due to trauma or infection. Some key symptoms of ophthalmoplegia include limiting eye movements in specific directions, double vision, drooping eyelids, and blurred vision. Surgeries such as strabismus surgery are performed to correct ocular misalignments caused by ophthalmoplegia.
The ophthalmoplegia market is estimated to be valued at USD 510 Mn in 2024 and is expected to reach USD 850 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
The current geopolitical instability across many parts of the world is impacting the growth of the Global Ophthalmoplegia Market. The ongoing conflicts and political uncertainties in key regions like Middle East and parts of Asia are negatively affecting the healthcare infrastructure and delivery. This is hampering the diagnosis and treatment of ophthalmoplegia cases. The economic sanctions and trade restrictions between some countries are disrupting supply chains and availability of important medical devices and drugs in the market.
Get More Insights On- Global Ophthalmoplegia Market
Get This Report in Japanese Language: 世界の眼筋麻痺市場
Get This Report in Korean Language: 글로벌 안근마비 시장
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian